Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats

Epirubicin is a chemotherapy agent for hepatocellular carcinoma (HCC). However, the outcome of HCC patients receiving epirubicin remains unsatisfactory. Moreover, our previous study indicated that celecoxib suppresses HCC progression and liver cancer stemness. This study evaluated the potential of c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Chu, Tian‐Huei, Chan, Hoi‐Hung, Hu, Tsung‐Hui, Wang, E‐Ming, Ma, Yi‐Ling, Huang, Shih‐Chung, Wu, Jian‐Ching, Chang, Yi‐Chen, Weng, Wen‐Tsan, Wen, Zhi‐Hong, Wu, Deng‐Chyang, Chen, Yi‐Ming Arthur, Tai, Ming‐Hong
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Cancer Biology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6010827/
https://ncbi.nlm.nih.gov/pubmed/29683262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1487
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados